Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in CELC — Celcuity Inc.

CIK 1446194 BALA CYNWYD, PA

Position in CELC

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,426,407
-$7,739,200 QoQ
Shares Held
12,497
-86.4% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
13 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CELC Over Time

Shares Held

Position Value (USD)

Derivatives in CELC

reported options exposure · as of Mar 31, 2026
CallValue
$65,116,870
CallShares
570,500
PutValue
$12,749,438
PutShares
111,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,173,997,525 across 354 Biotechnology names. CELC ranks #136 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CELC

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,426,407 12,497
2026-03-31 $12,749,438 111,700
2026-03-31 $65,116,870 570,500
2025-12-31 $30,650,102 307,300
2025-12-31 $9,165,607 91,895
2025-12-31 $10,223,350 102,500
2025-09-30 $5,285,800 107,000
2025-09-30 $9,168,640 185,600
2025-06-30 $536,670 40,200
2025-06-30 $287,025 21,500
2025-06-30 $795,993 59,625
2025-03-31 $404,713 40,031
2024-12-31 $212,058 16,200
2024-12-31 $279,026 21,316
2024-09-30 $371,259 24,900
2024-06-30 $237,788 14,517
2024-03-31 $200,880 9,300
2023-06-30 $141,674 12,903
2023-03-31 $103,525 10,100
2023-03-31 $929,910 90,723
2022-12-31 $184,651 13,180
2020-03-31 $71,721 11,034